HomeNKTR • NASDAQ
add
Nektar Therapeutics
Previous close
$1.01
Day range
$1.01 - $1.11
Year range
$0.42 - $1.93
Market cap
193.68M USD
Avg Volume
1.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 24.12M | -0.08% |
Operating expense | 53.99M | 19.40% |
Net income | -37.06M | 19.15% |
Net profit margin | -153.61 | 19.09% |
Earnings per share | -0.18 | 6.91% |
EBITDA | -33.31M | -4.71% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 244.50M | -34.39% |
Total assets | 307.97M | -30.36% |
Total liabilities | 259.08M | -8.41% |
Total equity | 48.88M | — |
Shares outstanding | 184.46M | — |
Price to book | 3.74 | — |
Return on assets | -26.33% | — |
Return on capital | -30.94% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -37.06M | 19.15% |
Cash from operations | -43.93M | -4.30% |
Cash from investing | 46.12M | -18.25% |
Cash from financing | 13.00K | — |
Net change in cash | 2.17M | -84.72% |
Free cash flow | -27.42M | -230.11% |
About
Founded
1990
Headquarters
Website
Employees
137
